Héloïse

Neuroscience project manager
at ETAP-Lab

[vion anne-clemence @AnCVion]

An assistant professor position is opening at the @institut_thorax. Great science, great environment and amazing colleague ! come to join us !

[Héloïse @Heloise_Lbs]

@PerseusLeGrand

[Héloïse @Heloise_Lbs]

New paper published recently 🎉
Imaging Cerebral Arteries Tortuosity and Velocities by Transcranial Doppler Ultrasound Is a Reliable Assessment of Brain Aneurysm in Mouse Models https://t.co/sse7LfNhi1
@Team6LVTSINSERM

[Ben Roussel @broussel10]

Dans le cadre du projet Groundstroke financé par @RegionNormandie le laboratoire @ViviensLab1 en collaboration avec @LoopDeeScience recrute un(e) IE pour 3 ans https://t.co/cAB4Q9X61d @BbCaen @Cyceron14 @InsermNordOuest @Inserm

[Jonathan Kipnis 🟦 @jonykipnis]

Very excited to share a new story from @kipnislab led by @Drieu_Antoine in collaboration with many others from within&outside our lab on parenchymal border macrophages (PBMs) in regulation of CSF flow with implications to aging and Alzheimer's disease || https://t.co/CbBWljpT2D

[Nature Methods @naturemethods]

Out today and freely available, a tool many in the image analysis community have been waiting for!

PyImageJ: A library for integrating ImageJ and Python

@EliceiriK @UWMadisonLOCI @ctrueden @CiminiLab @DrAnneCarpenter

https://t.co/2sjWSfJJ8n

[Team6LVTS@INSERM @Team6LVTSINSERM]

Good job Héloïse Lebas and Clémence Maupu on your poster presentation at the IVBM2022 in Oakland, CA #IVBM2022 . Keep up the good work !

[Max Lugavere @maxlugavere]

In a new paper in Nature, scientists looked at candidates for reversing dysregulated gene expression in Alzheimer's disease and guess what outperformed all tested drugs? Exercise.

Why isn't this front page news?

[RPTH @RPTHjournal]

PN-1 is a glycoprotein that inhibits thrombin and other proteases in the plasminergic system, but how can we measure it?
@Team6LVTSINSERM and colleagues developed a NOVEL lab assay to do just that! #RPTHMethods https://t.co/wPqOcimaM9

[Sara Martinez de Liz @S_MartinezDeLiz]

Thrilled to share our latest work in @ScienceAdvances. We have developped #ImmunoMRI method using #biodegradable & ultrasensitive microprobes #M3P, which allows immune diseases follow-up #IBD, #stroke, #MS...Thanks 🫶🏻 to funders & collaborators ⚫️🩻🧠https://t.co/9nvIY7ZSUE

[Héloïse @Heloise_Lbs]

Great pleasure to announce that our work "PAI-1 production by reactive astrocytes drives tissue dysfibrinolysis in multiple sclerosis models" is now available!
Many thanks to all co-authors https://t.co/QndjO3gllt
@ViviensLab1
@BbCaen
@fabian_docagne
@BoulayAC @CohenSalmonMar2

[Jérôme Parcq @jerome_parcq]

Congrats Estelle Louet, Ph.D, Martina Glavan for your work. Thank you Cyrille Orset for the supervision and Denis Vivien for the collaboration on this project !

bb@c, Blood and Brain Caen normandie; Inserm
#collaboration #preclinicalresearch https://t.co/9jYvZmczKm

[Héloïse @Heloise_Lbs]

@train_nomad Super, merci

[Ben Roussel @broussel10]

Submission for the 3rd ISFP & PA conference in Caen are open https://t.co/yxdFMjEdDS ➡️ Come and register, and spread the information!! @isth @kimpy79 @nikmutch @caterinacasari @DrZeZheng @InsermU1176 @JTHjournal @PatriciaLiaw @cecile_denis

[Team6LVTS@INSERM @Team6LVTSINSERM]

Reduced number of ICH & mortality among patients treated with glenzocimab (anti-GPVI ACT017) !

[Jonathan Kipnis 🟦 @jonykipnis]

Very excited to share our new story on the "missing link" for brain's immunity || Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma https://t.co/NsdFLOBNGD

[Arthur Liesz @ArthurLiesz]

Happy to share our new paper led by @st_heindl in @JExpMed: Why is Natalizumab not effective in the chronic phase after stroke? Because T cells proliferate chronically in the brain and evade the targeting by peripheral drugs! https://t.co/h3Dm4iKIcY

[Héloïse @Heloise_Lbs]

@G__Fischer France
2018
Female
4 women /3 men (3/2 without my supervisors)

PhD in biology (neuroscience)